lead position
Sponsored content
Sponsored by
GlobalBlock
Features list
-
The decision by a New York court in Myriad earlier this year left applicants facing an uphill battle to patent gene sequences. Michael Gollin and Rae Fischer explain how IP owners in the biotech sector can maximise protection for their innovations
-
Korean companies have traditionally been defendants in cases before the US International Trade Commission. Now they are likely to be plaintiffs. Alexander Koff considers whether Chinese businesses can make the same transition
-
IP owners often cooperate with business rivals to make their shared battle against fakes more effective. But staying on the right side of competition rules is vital. David Latham, Suzanne Rab and Laura Whiting provide a guide to getting the balance right
-
A recent ruling by the EPO on the patentability of software has done little to close the gap between EPO and UK interpretations of the law. Gwilym Roberts and Gareth Fennell explain where that leaves would-be applicants
-
Managing open source compliance can be complicated and costly. Mahshad Koohgoli and Sorin Cohn-Sfetcu analyse the strategies that companies can employ
-
EPC welcomes Kyrgyzstan as 75th member state
Local Insights